Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 9, 2004The Journal of Infectious DiseasesOpen Access

Protection against Congenital Cytomegalovirus Infection and Disease in Guinea Pigs, Conferred by a Purified Recombinant Glycoprotein B Vaccine

View Full Paper
Ask AI
Bookmark
Share

Authors

MSMark R. SchleissUniversity of MinnesotaNBNigel BourneThe University of Texas Medical Branch at GalvestonGSGreg StroupCincinnati Children's Hospital Medical Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Schleiss et al. (2004) studied this question.

synapsesocial.com/papers/6a71f0ada528af2d65c44158https://doi.org/10.1086/382751
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Herpes Simplex Virus (HSV) Type 2 Glycoprotein D Subunit Vaccines and Protection against Genital HSV‐1 or HSV‐2 Disease in Guinea Pigs2003 · 116 citations
  2. 2Vaccination against cytomegalovirus, the changeling demon1999 · 72 citations
  3. 3A Subunit Cytomegalovirus Vaccine Based on Recombinant Envelope Glycoprotein B and a New Adjuvant1999 · 253 citations
  4. 4Pathogenesis of Experimental Rhesus Cytomegalovirus Infection1999 · 116 citations
  5. 5Immunogenicity Evaluation of DNA Vaccines That Target Guinea Pig Cytomegalovirus Proteins Glycoprotein B and UL832000 · 35 citations